DLB · Dolby Laboratories, Inc.
$64.18
+1.48 (+2.36%)
At close · Aug 20
Market Cap
$5.84B
Shares
93.67M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$62.70
Open$61.54
Day$61.54–62.89
52W close$48.51–75.62
Avg vol 30d869K
Short int6.3M · 6.7% float · 6.5d
Short vol63%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 10 wks
FQ4-26 quarter ends
~Sep 27, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Moderate
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+4%
above
Price vs 50-day avg
+16%
above
RSI (14)
71
overbought
MACD trend
Positive
52-week position
52%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+28%
trailing
6-month return
−4%
trailing
YTD return
−2%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $54 › 200d $61 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +51 funds added
Insider flow
Distributing
Net -$753.1K over 90 days · 100% sells
Short interest
Falling
6.73% of float · ▼ -6.7% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
389 holders — near 3-yr low, contrarian setup
Squeeze score
74
high risk · 0–100
Fundamentals
Revenue growth
+10%
Y/Y
Gross margin
93%
contracting
EPS growth
−3%
Y/Y
Free cash flow
$435.9M
Valuation
P/E 26.7
in line
Buyback
$427.0M
remaining
Balance sheet
$701.9M
net cash
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
2.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
fourth quarter of fiscal 2026
Total revenue
Initiated
$362M – $392M
prior qtr $305M
midpoint +23.6% QoQ
Licensing revenue
Initiated
$335M – $365M
Gross margins
Initiated
90%
Gross margins
Initiated
88%
Operating expenses
Initiated
$195M – $205M
Effective tax rate
Initiated
23%
Operating expenses
Initiated
$227M – $237M
Effective tax rate
Initiated
21%
Diluted earnings per share
Initiated
$0.78 – $0.93
prior qtr $0.30
midpoint +185.0% QoQ
Diluted earnings per share
Initiated
$1.13 – $1.28
full year of fiscal 2026
Total revenue
Raised
$1.41B – $1.44B
Nov 18, 2025
$1.39B – $1.44B
changed to
Jul 30, 2026
$1.41B – $1.44B
prior FY $1.35B
midpoint +5.6% Y/Y
Licensing revenue
Raised
$1.31B – $1.34B
Nov 18, 2025
$1.29B – $1.34B
changed to
Jul 30, 2026
$1.31B – $1.34B
Gross margins
Maintained
88%
Nov 18, 2025
88%
changed to
Jul 30, 2026
88%
Gross margins
Maintained
90%
Nov 18, 2025
90%
changed to
Jul 30, 2026
90%
Operating expenses
Maintained
$785M – $795M
Nov 18, 2025
$780M – $800M
changed to
Jul 30, 2026
$785M – $795M
Operating expenses
Raised
$937M – $947M
Nov 18, 2025
$930M – $950M
changed to
Jul 30, 2026
$937M – $947M
Effective tax rate
Raised
24%
Nov 18, 2025
23%
changed to
Jul 30, 2026
24%
Diluted earnings per share
Raised
$2.62 – $2.77
Nov 18, 2025
$2.61 – $2.76
changed to
Jul 30, 2026
$2.62 – $2.77
prior FY $2.62
midpoint +2.9% Y/Y
Effective tax rate
Maintained
21%
Nov 18, 2025
21%
changed to
Jul 30, 2026
21%
Diluted earnings per share
Raised
$4.25 – $4.40
Nov 18, 2025
$4.19 – $4.34
changed to
Jul 30, 2026
$4.25 – $4.40
Prior guidance
period ended
· from the 8-K filed Apr 30, 2026
Total revenue
· third quarter of fiscal 2026
$295M – $325M
Licensing revenue
· third quarter of fiscal 2026
$270M – $300M
Gross margins
· third quarter of fiscal 2026
86%
Gross margins
· third quarter of fiscal 2026
88%
Effective tax rate
· third quarter of fiscal 2026
23%
Effective tax rate
· third quarter of fiscal 2026
21%
Guided vs delivered
· last 4 settled
Total revenue
first quarter of fiscal 2026
guided $315M – $345M
$346.71M
Beat +5.1%
Diluted earnings per share
first quarter of fiscal 2026
guided $0.39 – $0.54
$0.55
Beat +18.3%
Revenue
Q2 '24
guided $345M – $375M
$364.52M
In line
Revenue
Q1 '24
guided $300M – $330M
$315.57M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+4%
Bullish
Price vs 50-day avg
+16%
Bullish
RSI (14)
71
Bearish
MACD trend
Positive
Bullish
52-week position
52%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $54 › 200d $61 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +51 funds added
Insider flow
Distributing
Net -$753.1K over 90 days · 100% sells
Short interest
Falling
6.73% of float · ▼ -6.7% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
389 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $49
Now $63 · 52%
Range high $76
vs 200-day avg +4%
vs 50-day avg +16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| stock repurchase authorization available | $142M | Q2 FY2026 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DLB
this stock
Dolby Laboratories, Inc.
|
$5.84B | -2.4% | +10.3% | 26.7 | 6.7% |
|
CTAS
Cintas Corp
|
$81.38B | +8.0% | +6.4% | — | 2.8% |
|
RELX
Relx PLC
|
$62.04B | -13.2% | — | — | 0.2% |
|
TRI
Thomson Reuters Corp /Can/
|
$45.87B | -20.4% | — | — | 3.1% |
|
CPRT
Copart Inc
|
$30.93B | -13.5% | +24.7% | 20.9 | 4.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DLB | +2.1% | +27.6% | -4.2% | +6.6% | -2.4% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +2.6% | +24.7% | -15.8% | +3.7% | -15.2% |
Capital returns
Latest dividend
$0.36
/ share · ex Aug 11, 2026
Paid (TTM)
$1.44
/ share · 4 payouts
Dividend yield (TTM, derived)
2.30%
Buyback programs
· 2 active
· as of Jul 30, 2026
Authorized (total)
$777.00M
Spent (derived)
$350.00M
Remaining
$427.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
348 filings
345 filers
Visit website
Investor relations